A citation-based method for searching scientific literature

Aaron P Thrift, David C Whiteman. Cancer Epidemiol 2013
Times Cited: 16







List of co-cited articles
33 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Multiple imputation using chained equations: Issues and guidance for practice.
Ian R White, Patrick Royston, Angela M Wood. Stat Med 2011
18

Assessing the performance of prediction models: a framework for traditional and novel measures.
Ewout W Steyerberg, Andrew J Vickers, Nancy R Cook, Thomas Gerds, Mithat Gonen, Nancy Obuchowski, Michael J Pencina, Michael W Kattan. Epidemiology 2010
18

Maastricht Delphi consensus on event definitions for classification of recurrence in breast cancer research.
Martine Moossdorff, Lori M van Roozendaal, Luc J A Strobbe, Stefan Aebi, David A Cameron, J Michael Dixon, Armando E Giuliano, Bruce G Haffty, Brigid E Hickey, Clifford A Hudis,[...]. J Natl Cancer Inst 2014
52
18

Identifying individuals at high risk of melanoma: a practical predictor of absolute risk.
Thomas R Fears, DuPont Guerry, Ruth M Pfeiffer, Richard W Sagebiel, David E Elder, Allan Halpern, Elizabeth A Holly, Patricia Hartge, Margaret A Tucker. J Clin Oncol 2006
79
12

Upper endoscopy for gastroesophageal reflux disease: best practice advice from the clinical guidelines committee of the American College of Physicians.
Nicholas J Shaheen, David S Weinberg, Thomas D Denberg, Roger Chou, Amir Qaseem, Paul Shekelle. Ann Intern Med 2012
105
12

A model to determine absolute risk for esophageal adenocarcinoma.
Aaron P Thrift, Bradley J Kendall, Nirmala Pandeya, David C Whiteman. Clin Gastroenterol Hepatol 2013
58
12

Epidemiology of gastro-oesophageal reflux disease: a systematic review.
J Dent, H B El-Serag, M-A Wallander, S Johansson. Gut 2005
12

Cancer genome landscapes.
Bert Vogelstein, Nickolas Papadopoulos, Victor E Velculescu, Shibin Zhou, Luis A Diaz, Kenneth W Kinzler. Science 2013
12

Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma.
J Lagergren, R Bergström, A Lindgren, O Nyrén. N Engl J Med 1999
12

Risk prediction models of breast cancer: a systematic review of model performances.
Thunyarat Anothaisintawee, Yot Teerawattananon, Chollathip Wiratkapun, Vijj Kasamesup, Ammarin Thakkinstian. Breast Cancer Res Treat 2012
70
12

A simulation study of the number of events per variable in logistic regression analysis.
P Peduzzi, J Concato, E Kemper, T R Holford, A R Feinstein. J Clin Epidemiol 1996
12

Strategies for multiple imputation in longitudinal studies.
Michael Spratt, James Carpenter, Jonathan A C Sterne, John B Carlin, Jon Heron, John Henderson, Kate Tilling. Am J Epidemiol 2010
218
12

Projecting individualized probabilities of developing breast cancer for white females who are being examined annually.
M H Gail, L A Brinton, D P Byar, D K Corle, S B Green, C Schairer, J J Mulvihill. J Natl Cancer Inst 1989
12

Survival after locoregional recurrence or second primary breast cancer: impact of the disease-free interval.
Annemieke Witteveen, Annemiek B G Kwast, Gabe S Sonke, Maarten J IJzerman, Sabine Siesling. PLoS One 2015
13
15

Personalisation of breast cancer follow-up: a time-dependent prognostic nomogram for the estimation of annual risk of locoregional recurrence in early breast cancer patients.
Annemieke Witteveen, Ingrid M H Vliegen, Gabe S Sonke, Joost M Klaase, Maarten J IJzerman, Sabine Siesling. Breast Cancer Res Treat 2015
23
12

Prediction of cardiovascular risk using Framingham, ASSIGN and QRISK2: how well do they predict individual rather than population risk?
Tjeerd-Pieter van Staa, Martin Gulliford, Edmond S-W Ng, Ben Goldacre, Liam Smeeth. PLoS One 2014
35
12



Standard operating procedures for pre-analytical handling of blood and urine for metabolomic studies and biobanks.
Patrizia Bernini, Ivano Bertini, Claudio Luchinat, Paola Nincheri, Samuele Staderini, Paola Turano. J Biomol NMR 2011
177
12

Urine metabolic signature of pancreatic ductal adenocarcinoma by (1)h nuclear magnetic resonance: identification, mapping, and evolution.
Claudia Napoli, Nicola Sperandio, Rita T Lawlor, Aldo Scarpa, Henriette Molinari, Michael Assfalg. J Proteome Res 2012
48
12

NMR-based fecal metabolomics fingerprinting as predictors of earlier diagnosis in patients with colorectal cancer.
Yan Lin, Changchun Ma, Chengkang Liu, Zhening Wang, Jurong Yang, Xinmu Liu, Zhiwei Shen, Renhua Wu. Oncotarget 2016
60
12


Feasibility of identifying pancreatic cancer based on serum metabolomics.
Oliver F Bathe, Rustem Shaykhutdinov, Karen Kopciuk, Aalim M Weljie, Andrew McKay, Francis R Sutherland, Elijah Dixon, Nicole Dunse, Dina Sotiropoulos, Hans J Vogel. Cancer Epidemiol Biomarkers Prev 2011
111
12

Distinguishing pancreatic cancer from chronic pancreatitis and healthy individuals by (1)H nuclear magnetic resonance-based metabonomic profiles.
Lin Zhang, Haifeng Jin, Xuegang Guo, Zhao Yang, Lina Zhao, Shanhong Tang, Ping Mo, Kaichun Wu, Yongzhan Nie, Yanglin Pan,[...]. Clin Biochem 2012
48
12

Pancreatic ductal adenocarcinoma is associated with a distinct urinary metabolomic signature.
Vanessa W Davis, Daniel E Schiller, Dean Eurich, Oliver F Bathe, Michael B Sawyer. Ann Surg Oncol 2013
32
12

Multivariate modeling and prediction of breast cancer prognostic factors using MR metabolomics.
Guro F Giskeødegård, Maria T Grinde, Beathe Sitter, David E Axelson, Steinar Lundgren, Hans E Fjøsne, Steinar Dahl, Ingrid S Gribbestad, Tone F Bathen. J Proteome Res 2010
87
12

Metabolite profiling of fecal water extracts from human colorectal cancer.
Daniel Monleón, José Manuel Morales, Antonio Barrasa, Jose Antonio López, Carlos Vázquez, Bernardo Celda. NMR Biomed 2009
122
12

The Emerging Hallmarks of Cancer Metabolism.
Natalya N Pavlova, Craig B Thompson. Cell Metab 2016
12


Metabolomic NMR fingerprinting to identify and predict survival of patients with metastatic colorectal cancer.
Ivano Bertini, Stefano Cacciatore, Benny V Jensen, Jakob V Schou, Julia S Johansen, Mogens Kruhøffer, Claudio Luchinat, Dorte L Nielsen, Paola Turano. Cancer Res 2012
119
12

Metabotyping of long-lived mice using 1H NMR spectroscopy.
Anisha Wijeyesekera, Colin Selman, Richard H Barton, Elaine Holmes, Jeremy K Nicholson, Dominic J Withers. J Proteome Res 2012
41
12

Metabolic signatures of malignant progression in prostate epithelial cells.
Orla Teahan, Charlotte L Bevan, Jonathan Waxman, Hector C Keun. Int J Biochem Cell Biol 2011
39
12


A critical review of the biopsychosocial model.
N McLaren. Aust N Z J Psychiatry 1998
61
6



Subsensitivity of serotonin receptors after long-term treatment of rats with fluoxetine.
D T Wong, F P Bymaster. Res Commun Chem Pathol Pharmacol 1981
44
6





Reexamining adaptation and the set point model of happiness: reactions to changes in marital status.
Richard E Lucas, Andrew E Clark, Yannis Georgellis, Ed Diener. J Pers Soc Psychol 2003
193
6

Subjective well-being and adaptation to life events: a meta-analysis.
Maike Luhmann, Wilhelm Hofmann, Michael Eid, Richard E Lucas. J Pers Soc Psychol 2012
236
6



Homeostasis: a plea for a unified approach.
R H S Carpenter. Adv Physiol Educ 2004
38
6



Measuring delusional ideation: the 21-item Peters et al. Delusions Inventory (PDI).
Emmanuelle Peters, Stephen Joseph, Samantha Day, Philippa Garety. Schizophr Bull 2004
302
6

Epigenetics and the environmental regulation of the genome and its function.
Tie-Yuan Zhang, Michael J Meaney. Annu Rev Psychol 2010
272
6


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.